| Item Type | Name |
|
Academic Article
|
Twenty-four-hour cortisol secretion patterns in prepubertal children with anxiety or depressive disorders.
|
|
Academic Article
|
Neurobiology of anxiety disorders and implications for treatment.
|
|
Academic Article
|
Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study.
|
|
Academic Article
|
Etiology and neurobiology of social anxiety disorder.
|
|
Academic Article
|
Riluzole effect on occipital cortex: a structural and spectroscopy pilot study.
|
|
Academic Article
|
Glutamate and anxiety disorders.
|
|
Academic Article
|
Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.
|
|
Academic Article
|
Anxiety and depression: leading edge of therapy.
|
|
Academic Article
|
Anxiety disorders: a comprehensive review of pharmacotherapies.
|
|
Academic Article
|
Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label study.
|
|
Academic Article
|
Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study.
|
|
Academic Article
|
The role of early life stress in development of the anterior limb of the internal capsule in nonhuman primates.
|
|
Academic Article
|
Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.
|
|
Academic Article
|
The Relationship between Intelligence and Anxiety: An Association with Subcortical White Matter Metabolism.
|
|
Academic Article
|
Early-life stress, corpus callosum development, hippocampal volumetrics, and anxious behavior in male nonhuman primates.
|
|
Academic Article
|
A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD.
|
|
Academic Article
|
Open-label trial of riluzole in generalized anxiety disorder.
|
|
Academic Article
|
Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma.
|
|
Academic Article
|
Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.
|
|
Academic Article
|
Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
|
|
Academic Article
|
Treatment-resistant depression: recent developments and future directions.
|
|
Concept
|
Anxiety Disorders
|
|
Concept
|
Anti-Anxiety Agents
|
|
Concept
|
Anxiety
|
|
Academic Article
|
Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight.
|
|
Academic Article
|
Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.
|
|
Academic Article
|
Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid in macaques following early life stress and inverse association with hippocampal volume: preliminary implications for serotonin-related function in mood and anxiety disorders.
|
|
Academic Article
|
A Novel Anxiety and Affective Spectrum Disorder of Mind and Body-The ALPIM (Anxiety-Laxity-Pain-Immune-Mood) Syndrome: A Preliminary Report.
|
|
Academic Article
|
Impact of childhood emotional abuse on neocortical neurometabolites and complex emotional processing in patients with generalized anxiety disorder.
|
|
Academic Article
|
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
|
|
Academic Article
|
Neurobiology of the dorsolateral prefrontal cortex in GAD: Aberrant neurometabolic correlation to hippocampus and relationship to anxiety sensitivity and IQ.
|
|
Academic Article
|
The Neurobiological Mechanisms of Generalized Anxiety Disorder and Chronic Stress.
|
|
Academic Article
|
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.
|
|
Grant
|
PROTON MRS STUDIES IN GENERALIZED ANXIETY DISORDER
|
|
Grant
|
2/3-Efficacy and Tolerability of Riluzole in Treatment-Resistant Depression
|
|
Grant
|
NMDA receptor modulation for hyperarousal in PTSD
|
|
Academic Article
|
Trajectories of self-reported sleep disturbance across inpatient psychiatric treatment predict clinical outcome in comorbid major depressive disorder and generalized anxiety disorder.
|
|
Academic Article
|
Novel investigational therapeutics for generalized anxiety disorder (GAD).
|
|
Academic Article
|
Psychotherapy for Mixed Depression and Mixed Mania.
|
|
Academic Article
|
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating ?-opioid antagonism as a treatment for anhedonia.
|
|
Academic Article
|
Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).
|
|
Academic Article
|
Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: A randomized, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).
|
|
Academic Article
|
The why, when, where, how, and so what of so-called rapidly acting antidepressants.
|